Spain employs new communication tools to reduce waiting lists

The enhancement of telemedicine during the Covid-19 pandemic helped speeding up patient care, but it has also proven to be effective in strengthening connections between medical professionals themselves. Pilot tests applied in several communities in Spain have revealed the success of this tool in opening a direct line of communication between primary care and medical specialists (link in Spanish). The pilots have already resulted in the reduction of waiting lists for hospital consultations. The Spanish regions of Murcia, Navarra, Andalusia, as well as the city of Madrid have already implemented experimental programs that allow primary school doctors to conduct real time consultations with medical specialists. In less than 24 hours, they receive a response that helps them decide if the problem is serious, hence a referral is necessary.

Related News

All News

Willum Þór: The question remains if our healthcare system is sustainable

On January 1st, Iceland took over the Presidency of the Nordic Council of Ministers. This intergovernmental organisation plays an important role in promoting innovations, health data integration, and cooperation between all major stakeholders in the Nordic healthcare. The Icelandic Health Minister elaborates on his vision to future health in the Nordic region, the Nordic strengths, Iceland’s plans for the Presidency with regards to health innovations, and the coming collaboration with Copenhagen Institute for Futures Studies

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner